Eli Lilly loses latest round in UK drug patent battle
February 12, 2016 at 08:09 AM EST
LONDON, Feb 12 (Reuters) - Eli Lilly said on Friday it lost the latest round of a lengthy patent saga over its blockbuster Alimta lung cancer drug in the UK High Court, in a boost for generic drugmaker Actavis, now renamed Allergan .
